Spectrofluorimetric protocol for ceftriaxone in commercial formulation and human plasma after condensation with formaldehyde and ethyl acetoacetate

Journal of Fluorescence

Volumn 21, Issue 6, 2011, Pages 2155-2163

  Shah, Jasmin ^a   Jan, M Rasul ^a,b   Shah, Sultan ^a   Naeem, M ^a  

^a UNIVERSITY OF PESHAWAR   (Pakistan)

^b UNIVERSITY OF MALAKAND   (Pakistan)

Author keywords

Ceftriaxone; Ethyl acetoacetate; Formaldehyde; Spectrofluorimetric; Spiked human plasma

Indexed keywords

CONDENSATION; COST EFFECTIVENESS; FLUORESCENCE; FORMALDEHYDE; PLASMA (HUMAN);

CEFTRIAXONE; CORRELATION COEFFICIENT; ETHYLACETOACETATE; LIMIT OF QUANTIFICATIONS; PHARMACEUTICAL FORMULATION; SPECTROFLUORIMETRIC; SPECTROFLUORIMETRIC METHODS; SPIKED HUMAN PLASMAS;

CONDENSATION REACTIONS;

EID: 84856303670     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10895-011-0917-0     Document Type: Article

References (33)

1. Amin AS, Ragab GH (2004) Spectrophotometric determination of certain cephalosporins in pure form and in pharmaceutical formulations. Spectrochimica Acta Part A 60:2831-2835
2. Angehrn P, Probst PJ, Reiner R, Then RL (1980) Ro 13-9904, A long-acting broad-spectrum cephalosporin: in vitro and in vivo studies. Antimicrob Agents Chemother 18:913-921 (Pubitemid 11182992)
3. Beam TR Jr (1985) Ceftriaxone: a beta-lactamase-stable, broadspectrum cephalosporin with an extended half-life. Pharmacotherapy 5:237-253 (Pubitemid 16223216)
4. Neu HC (1987) Cephalosporins in the treatment of meningitis. Drugs 34:135-153 (Pubitemid 17154379)
5. Owens HM, Destache CJ, Dash AK (1999) Simple liquid chromatographic method for the analysis of the blood brain barrier permeability characteristics of ceftriaxone in an experimental rabbit meningitis model. J Chromatogr B 728:97-105 (Pubitemid 29216966)
6. Balant L, Dayer P, Auckenthaler R (1985) Clinical pharmacokinetics of the third generation cephalosporins. Clin Pharmacokinet 10:101-143 (Pubitemid 15104996)
7. Kovar A, Dalla Costa T, Derendorf H (1997) Comparison of plasma and free tissue levels of ceftriaxone in rats by microdialysis. J Pharm Sci 86:52-56 (Pubitemid 127489657)
8. Soback S, Ziv G (1988) Pharmacokinetics and bioavailability of ceftriaxone administered intravenously and intramuscularly in calves. Am J Vet Res 49:535-538
9. Bergan T (1987) Pharmacokinetic properties of the cephalosporins. Drugs 34:89-104 (Pubitemid 17154376)
10. Meyers BR, Srulevitch ES, Jacobson J, Hirschman SZ (1983) Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers. Antimicrob Agents Chemother 24:812-814 (Pubitemid 14203889)
11. Ismail MM(2005) Pharmacokinetics, urinary andmammary excretion of ceftriaxone in lactating goats. J Vet Med Series A 52:354-358 (Pubitemid 41641047)
12. Zhou HH, Chan YPM, Arnold K, Sun M (1985) Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults. Antimicrob Agents Chemother 27:192-196 (Pubitemid 15002429)
13. Bourget P, Fernandez H, Quinquis V, Delouis C (1993) Pharmacokinetics and protein binding of ceftriaxone during pregnancy. Antimicrob Agents Chemother 37(1):54-59 (Pubitemid 23019169)
14. 1 in plasma, urine, and bile by means of ion-pair reversed phase chromatography. J High Resolut Chromatogr 4(2):54-59
15. Abdel-Hamid ME (1998) FSQ spectrophotometric and HPLC analysis of some cephalosporins in the presence of their alkaliinduced degradation products. IL Farmaco 53:132-138 (Pubitemid 29101306)
16. Hakim L, Bourne DW, Triggs EJ (1988) High-performance liquid chromatographic assay of cefotaxime, desacetylcefotaxime and ceftriaxone in rat plasma. J Chromatogr 424(1):111-117 (Pubitemid 18041123)
17. Jungbluth GL, Jusko WJ (1989) Ion-paired reversed-phase highperformance liquid chromatography assay for determination of ceftriaxone in human plasma and urine. J Pharm Sci 78(11):968-970 (Pubitemid 20096279)
18. Hiremath B, Mruthyunjayaswamy BHM (2009) Development and validation of a high performance liquid chromatographic determination of ceftriaxone sodium and its application to drug quality control. Anal Lett 42:2180-2191
19. Shrivastava SM, Singh R, Tariq A, Siddiqui MR, Yadav J, Negi PS, Chaudhary M (2009) A novel high performance liquid chromatographic method for simultaneous determination of ceftriaxone and sulbactam in sulbactomax. Int J Biomed Sci 5:37-43
20. Nemutlua E, Kir S, Katlan D, Beksac MS (2009) Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: application to validation and quantification of cefepime, cefixime and cefoperazone. Talanta 80:117-126
21. Granich GG, Krogstad DJ (1987) Ion pair high performance liquid chromatographic assay for ceftriaxone. Antimicrob Agents Chemother 31(3):385-388 (Pubitemid 17027125)
22. Khasanov VV, Sokolovich EG, Dychko KA (2006) Determination of ceftriaxone in blood and tissues using ion-exchange chromatography. Pharmaceut Chem J 40(2):47-49
23. Pajchel G, Tyski S (2000) Adaptation of capillary electrophoresis to the determination of selected cephalosporins for injection. J Chromatogr A 895:27-31
24. Reddy GVS, Reddy SJ (1997) Estimation of cephalosporin antibiotics by differential pulse polarography. Talanta 44:627-631 (Pubitemid 27210490)
25. Zhang D, Ma Y, Zhou M, Li L, Chen H (2006) Determination of ceftriaxone sodium in pharmaceutical formulation by flow injection analysis with Acid potassium permanganate chemiluminescence detection. Anal Sci 22:183-186
26. Al-Momani IF (2001) Spectrophotometric determination of selected cephalosporins in drug formulation using flow injection analysis. J Pharm Biomed Anal 25:751-757 (Pubitemid 32488939)
27. El-Walily AFM, Gazy AA, Belal SF, Khamis EF (2000) Quantitative determination of some thiazole cephalosporins through complexation with palladium (II) chloride. J Pharm Biomed Anal 22:385-392 (Pubitemid 30109359)
28. El Walily AFM, Gazy AAK, Belal SF, Khamis EF (2000) Use of cerium (IV) in the spectrophotometric and spectrofluorimetric determinations of penicillins and cephalosporins in their pharmaceutical preparations. Spectrosc Lett 33(6):931-948
29. Saleh GA, El-Shaboury SR, Mohamed FA, Rageh AH (2009) Kinetic spectrophotometric determination of certain cephalosporins using oxidized quercetin reagent. Spectrochimica Acta Part A 73:946-954
30. Nakanomyo H, Hiraoka M, Kidono M (1990) Microbiological assay method of BMY-28100 and some other cephem antibiotic in serum and tissues, development of new sample preparation with Evan's blue. Jpn J Antibiot 43(9):1538-1544 (Pubitemid 20336576)
31. 3+). J Pharm Biomed Anal 32:1219-1225 (Pubitemid 36934512)
32. Omar MA, Abdelmageed OH, Attia TZ (2009) Kinetic Spectrofluorimetric determination of certain cephalosporins in human plasma. Talanta 77:1394-1404
33. Belliveau PP, Freeman CD, Nicolau DP, Nightingale CH, Tessier PR, Quintiliani R (1996) Serum bactericidal activity of ceftizoxime and ceftriaxone against pathogens associated with community-acquired and nosocomial pneumonias. Am J Health-Syst Pharm 53(9):1024-1027 (Pubitemid 26139494)